SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
Tigher
Lv1
40 积分
2022-09-08 加入
最近求助
最近应助
互助留言
AK112, a novel PD-1/VEGF bispecific antibody, in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC): an open-label, multicenter, phase II trial
2天前
已完结
The Intersection between Tumor Angiogenesis and Immune Suppression
3天前
已完结
Mechanisms and regulation of endothelial VEGF receptor signalling
3天前
已完结
Best Supportive Care in Advanced Pancreatic Cancer
8天前
已完结
'Best supportive care' has had its day
8天前
已完结
Defining Best Supportive Care
8天前
已完结
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
16天前
已完结
Circulating biomarkers of bevacizumab activity in patients with breast cancer
16天前
已完结
High VEGF-A level at baseline predicts poor treatment effect of bevacizumab-based chemotherapy in metastatic colorectal cancer: a meta-analysis
16天前
已关闭
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
16天前
已完结
没有进行任何应助
感谢
2天前
感谢
3天前
感谢
3天前
感谢
1个月前
感谢
1个月前
感谢
1个月前
感谢
1个月前
感谢
2个月前
感谢
2个月前
感谢
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论